Cargando…
Are anticoagulants still indicated in pulmonary arterial hypertension?
Pulmonary arterial hypertension (PAH) is a type of pulmonary hypertension that is a progressive, fatal disease. Multiple underlying mechanisms for PAH have been identified, including vasoconstriction, intimal proliferation, medial hypertrophy, inflammation, mitochondrial dysfunction, and in situ thr...
Autores principales: | Olschewski, Horst, Rich, Stuart |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6202749/ https://www.ncbi.nlm.nih.gov/pubmed/30284508 http://dx.doi.org/10.1177/2045894018807681 |
Ejemplares similares
-
Pulmonary vasodilators: beyond the bounds of pulmonary arterial hypertension
therapy in COVID-19
por: Franco, Veronica, et al.
Publicado: (2020) -
United States Pulmonary Hypertension Scientific Registry (USPHSR): rationale, design, and clinical implications
por: Elliott, C. Gregory, et al.
Publicado: (2019) -
Early intervention: should we conduct therapeutic trials for mild
pulmonary hypertension before onset of symptoms?
por: Huston, Jessica H., et al.
Publicado: (2019) -
The use of chromoendoscopy for surveillance of inflammatory bowel disease
por: Lichtenstein, Gary R., et al.
Publicado: (2018) -
Trade in wild animals: a disaster ignored
por: The Lancet Infectious Diseases
Publicado: (2003)